EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrated New Approach Methodologies Reveal the Potential Role of 2,7-Dibromocarbazole in Parkinson’s Disease via Monoamine Oxidase B Inhibition and Dopaminergic Dysfunction

Xinhe Lu, Yuhang Luo, Pei Peng, Xingyue Xing, Wei Xia iD, Hongyan Yin, Hanzeng Li iD, Shunqing Xu

Environmental Science & Technology · 2026

DOI: 10.1021/acs.est.5c14167 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Science & Technology, 2026. Verfasst von Xinhe Lu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Environmental and Science and Engineering, Hainan University, Haikou 570228, China. Hauptthemen laut MEDLINE: Carbazoles, Parkinson Disease. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Hainan Province, Innovation Fund for Scientific and Technological Personnel of Hainan Province, Collaborative Innovation Center of One Health, Hainan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The neurotoxicity of emerging contaminants, polyhalogenated carbazoles (PHCZs), is elusive. In this study, we investigated the potential toxicity of 13 prevalent PHCZs utilizing a network toxicology approach, which revealed shared molecular targets associated with Parkinson's disease (PD). Molecular docking simulations assessed the binding affinities of these PHCZs for eight key PD-related targets, identifying monoamine oxidase B (MAOB) as a critical target. Among the dihalogenated PHCZs, 2,7-dibromocarbazole (2,7-BCZ) exhibited the highest binding affinity to MAOB. Comparative molecular docking and dynamics simulations suggest that the inhibition of MAOB activity by 2,7-BCZ is a potential initiating event in PHCZ-induced neurological disorders. In vivo experiments confirmed that 2,7-BCZ exposure highly correlates with α-synuclein aggregation, a hallmark of PD pathology. Transcriptomic sequencing of 2,7-BCZ-exposed SH-SY5Y cells, combined with analysis of public PD microarray data, identified shared transcriptional alterations in genes including CLSTN2, CBLN1, AGTR1, DLK1, and DDC. By integrating pathways from PD-related targets of PHCZs, differentially expressed genes in 2,7-BCZ-exposed cells, and public PD data sets, we further elucidated key biological pathways through which 2,7-BCZ may contribute to PD pathogenesis, particularly dopaminergic synapse function and neurodevelopmental regulation. Collectively, this study not only highlights the potential role of PHCZs in PD, elucidating the potential biological mechanisms by which PHCZs may exacerbate PD, but also exemplifies an innovative, animal-sparing approach using New Approach Methodologies (NAMs) to assess environmental pollutants' risks in neurodegenerative adverse outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarbazolesParkinson DiseaseHumansMonoamine OxidaseAnimalsMolecular Docking SimulationMonoamine Oxidase InhibitorsDopamine

Stichwörter der Autor:innen

PHCZsParkinson’s diseasenetwork toxicologyneurotoxicitytranscriptomic analysis

Substanzen

CarbazolesMonoamine OxidaseMonoamine Oxidase InhibitorsDopamine

Autor:innen und Institutionen

  • School of Environmental and Science and Engineering, Hainan University, Haikou 570228, China.
  • Key Laboratory of Environment and Health (HUST), Ministry of Education & Ministry of Environmental Protection, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei…
  • School of Life and Health Sciences, Hainan University, Haikou 570228, China.
  • School of Tropical Agriculture and Forestry, Hainan University, Haikou 570228, China.

ORCID-Profile: Wei Xia, Hanzeng Li

Förderung

  • Natural Science Foundation of Hainan Province
  • Innovation Fund for Scientific and Technological Personnel of Hainan Province
  • Collaborative Innovation Center of One Health, Hainan University
  • National Natural Science Foundation of China (NSFC)

Zitieren

APA

Lu, X., Luo, Y., Peng, P., Xing, X., Xia, W., Yin, H., Li, H., & Xu, S. (2026). Integrated New Approach Methodologies Reveal the Potential Role of 2,7-Dibromocarbazole in Parkinson’s Disease via Monoamine Oxidase B Inhibition and Dopaminergic Dysfunction. Environmental Science & Technology. https://doi.org/10.1021/acs.est.5c14167

Vancouver

Lu X, Luo Y, Peng P, Xing X, Xia W, Yin H, et al. Integrated New Approach Methodologies Reveal the Potential Role of 2,7-Dibromocarbazole in Parkinson’s Disease via Monoamine Oxidase B Inhibition and Dopaminergic Dysfunction. Environmental Science & Technology. 2026. doi:10.1021/acs.est.5c14167

BibTeX
@article{Lu2026,
  author = {Lu, Xinhe and Luo, Yuhang and Peng, Pei and Xing, Xingyue and Xia, Wei and Yin, Hongyan and Li, Hanzeng and Xu, Shunqing},
  title = {Integrated New Approach Methodologies Reveal the Potential Role of 2,7-Dibromocarbazole in Parkinson’s Disease via Monoamine Oxidase B Inhibition and Dopaminergic Dysfunction},
  journal = {Environmental Science & Technology},
  year = {2026},
  doi = {10.1021/acs.est.5c14167}
}
Kostenlos starten →